Complement component 3C3 and C3a receptor are required in chitin-dependent allergic sensitization to Aspergillus fumigatus but dispensable in chitin-induced innate allergic inflammation

mBio

Volumn 4, Issue 2, 2013, Pages

  Roy, René M ^a   Paes, Hugo C ^a   Nanjappa, Som G ^a   Sorkness, Ron ^b   Gasper, David ^b   Sterkel, Alana ^a   Wüthrich, Marcel ^a   Kleina, Bruce S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITIN; COMPLEMENT COMPONENT 3C3 RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT RECEPTOR; CYTOKINE; FUNGUS ANTIGEN; IMMUNOGLOBULIN E; UNCLASSIFIED DRUG; COMPLEMENT C3A RECEPTOR; COMPLEMENT COMPONENT C3;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; ASPERGILLUS FUMIGATUS; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; DENDRITIC CELL; INNATE IMMUNITY; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; TH17 CELL; TH2 CELL; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANIMAL; GENETICS; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; CHITIN; COMPLEMENT C3; DENDRITIC CELLS; MICE; MICE, KNOCKOUT; RECEPTORS, COMPLEMENT; T-LYMPHOCYTES;

EID: 84880047772     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00162-13     Document Type: Article

References (56)

1. Agarwal R, Nath A, Aggarwal AN, Gupta D, Chakrabarti A. 2010. Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in North India. Mycoses 53:138-143.
2. Fairs A, Agbetile J, Hargadon B, Bourne M, Monteiro WR, Brightling CE, Bradding P, Green RH, Mutalithas K, Desai D, Pavord ID, Wardlaw AJ, Pashley CH. 2010. IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am. J. Respir. Crit. Care Med. 182:1362-1368.
3. Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169:5904-5911.
4. Kiss A, Montes M, Susarla S, Jaensson EA, Drouin SM, Wetsel RA, Yao Z, Martin R, Hamzeh N, Adelagun R, Amar S, Kheradmand F, Corry DB. 2007. A new mechanism regulating the initiation of allergic airway inflammation. J. Allergy Clin. Immunol. 120:334-342.
5. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. 1991. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J. Exp. Med. 173:1345-1356.
6. Sung SS, Fu SM, Rose CE, Gaskin F, Ju ST, Beaty SR. 2006. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing langerin and tight junction proteins. J. Immunol. 176: 2161-2172.
7. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH, Berry G, DeKruyff RH, Umetsu DT. 2002. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 8:1024-1032.
8. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït-Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.
9. Hochweller K, Anderton SM. 2005. Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo. Eur. J. Immunol. 35:1086-1096.
10. Osterholzer JJ, Chen GH, Olszewski MA, Curtis JL, Huffnagle GB, Toews GB. 2009. Accumulation of CD11b_ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes. J. Immunol. 183: 8044-8053.
11. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, Karp CL. 2009. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457:585-588.
12. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN. 2009. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15:410- 416.
13. van Rijt LS, Jung S, Kleinjan A, Vos N, Willart M, Duez C, Hoogsteden HC, Lambrecht BN. 2005. In vivo depletion of lung CD11c_ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201:981-991.
14. Carroll MC. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16: 545-568.
15. Zwirner J, Götze O, Begemann G, Kapp A, Kirchhoff K, Werfel T. 1999. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology 97:166-172.
16. Drouin SM, Kildsgaard J, Haviland J, Zabner J, Jia HP, McCray PB, Tack BF, Wetsel RA. 2001. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J. Immunol. 166:2025-2032.
17. Li K, Anderson KJ, Peng Q, Noble A, Lu B, Kelly AP, Wang N, Sacks SH, Zhou W. 2008. Cyclic AMP plays a critical role in C3a-receptormediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 112:5084-5094.
18. Maubon D, Park S, Tanguy M, Huerre M, Schmitt C, Prévost MC, Perlin DS, Latgé JP, Beauvais A. 2006. AGS3, an alpha, (1-3)glucan synthase gene family member of Aspergillus fumigatus, modulates mycelium growth in the lung of experimentally infected mice. Fungal Genet. Biol. 43: 366-375.
19. Kaku H, Nishizawa Y, Ishii-Minami N, Akimoto-Tomiyama C, Dohmae N, Takio K, Minami E, Shibuya N. 2006. Plant cells recognize chitin fragments for defense signaling through a plasma membrane receptor. Proc. Natl. Acad. Sci. U. S. A. 103:11086-11091.
20. Cuesta A, Esteban MA, Meseguer J. 2003. In vitro effect of chitin particles on the innate cellular immune system of gilthead seabream (Sparus aurata L.). Fish Shellfish Immunol. 15:1-11. DOI: 10.1016/S1050-4648(02)00134-1. PubMed.
21. Reese TA, Liang HE, Tager AM, Luster AD, Van Rooijen N, Voehringer D, Locksley RM. 2007. Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 447:92-96.
22. Roy RM, Wuthrich M, Klein BS. 2012. Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. J. Immunol. 189:2545-2552.
23. Da Silva CA, Pochard P, Lee CG, Elias JA. 2010. Chitin particles are multifaceted immune adjuvants. Am. J. Respir. Crit. Care Med. 182: 1482-1491.
24. Van Dyken SJ, Garcia D, Porter P, Huang X, Quinlan PJ, Blanc PD, Corry DB, Locksley RM. 2011. Fungal chitin from asthma-associated home environments induces eosinophilic lung infiltration. J. Immunol. 187:2261-2267.
25. Dickey BF. 2007. Exoskeletons and exhalation. N. Engl. J. Med. 357: 2082-2084.
26. Rapaka RR, Ricks DM, Alcorn JF, Chen K, Khader SA, Zheng M, Plevy S, Bengtén E, Kolls JK. 2010. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J. Exp. Med. 207:2907-2919.
27. Koth LL, Rodriguez MW, Bernstein XL, Chan S, Huang X, Charo IF, Rollins BJ, Erle DJ. 2004. Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2. Respir. Res. 5:12.
28. Behnsen J, Lessing F, Schindler S, Wartenberg D, Jacobsen ID, Thoen M, Zipfel PF, Brakhage AA. 2010. Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect. Immun. 78:3585-3594.
29. Nagata S, Glovsky MM. 1987. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation. J. Allergy Clin. Immunol. 80: 24-32.
30. Fei M, Bhatia S, Oriss TB, Yarlagadda M, Khare A, Akira S, Saijo S, Iwakura Y, Fallert Junecko BA, Reinhart TA, Foreman O, Ray P, Kolls J, Ray A. 2011. TNF-alpha from inflammatory dendritic cells (DCs) regulates lung IL-17A/IL-5 levels and neutrophilia versus eosinophilia during persistent fungal infection. Proc. Natl. Acad. Sci. U. S. A. 108: 5360-5365.
31. Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, Bleecker ER, National Heart, Lung, and Blood Institute Severe Asthma Research Program. 2010. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J. Allergy Clin. Immunol. 125:1028-1036. PubMed.
32. Wark PA, Saltos N, Simpson J, Slater S, Hensley MJ, Gibson PG. 2000. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur. Respir. J. 16:1095-1101.
33. de Heer HJ, Hammad H, Soullié T, Hijdra D, Vos N, Willart MA, Hoogsteden HC, Lambrecht BN. 2004. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200:89-98.
34. Zhang X, Lewkowich IP, Köhl G, Clark JR, Wills-Karp M, Köhl J. 2009. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells. J. Immunol. 182:5123-5130.
35. Abe M, Wang Z, de Creus A, Thomson AW. 2005. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 5:1808-1819.
36. Hasegawa K, Tamari M, Shao C, Shimizu M, Takahashi N, Mao XQ, Yamasaki A, Kamada F, Doi S, Fujiwara H, Miyatake A, Fujita K, Tamura G, Matsubara Y, Shirakawa T, Suzuki Y. 2004. Variations in the C3, C3a receptor, and C5 genes affect susceptibility to bronchial asthma. Hum. Genet. 115:295-301.
37. Nakano Y, Morita S, Kawamoto A, Suda T, Chida K, Nakamura H. 2003. Elevated complement C3a in plasma from patients with severe acute asthma. J. Allergy Clin. Immunol. 112:525-530.
38. Walters DM, Breysse PN, Schofield B, Wills-Karp M. 2002. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am. J. Respir. Cell. Mol. Biol. 27:413-418.
39. Kanemitsu H, Nagasawa S, Sagai M, Mori Y. 1998. Complement activation by diesel exhaust particles (DEP). Biol. Pharm. Bull. 21:129-132.
40. Park JW, Taube C, Joetham A, Takeda K, Kodama T, Dakhama A, McConville G, Allen CB, Sfyroera G, Shultz LD, Lambris JD, Giclas PC, Holers VM, Gelfand EW. 2004. Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am. J. Respir. Crit. Care Med. 169:726-732.
41. Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, Brückner UB, Nilsson B, Gebhard F, Lambris JD, Huber-Lang M. 2010. Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185:5628-5636.
42. Zhang X, Köhl J. 2010. A complex role for complement in allergic asthma. Expert Rev. Clin. Immunol. 6:269-277.
43. Drouin SM, Corry DB, Kildsgaard J, Wetsel RA. 2001. Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 167: 4141-4145.
44. Drouin SM, Corry DB, Hollman TJ, Kildsgaard J, Wetsel RA. 2002. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 169:5926-5933.
45. DiScipio RG, Daffern PJ, Jagels MA, Broide DH, Sriramarao P. 1999. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol. 162:1127-1136.
46. Da Silva CA, Hartl D, Liu W, Lee CG, Elias JA. 2008. TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation. J. Immunol. 181:4279-4286.
47. Park SY, Jing X, Gupta D, Dziarski R. 18 February 2013, posting date. Peptidoglycan recognition protein 1 enhances experimental asthma by promoting Th2 and Th17 and limiting regulatory T cell and plasmacytoid dendritic cell responses. J. Immunol. http://dx.doi.org/10.4049/jimmunol.1202675.
48. Hawlisch H, Wills-Karp M, Karp CL, Köhl J. 2004. The anaphylatoxins bridge innate and adaptive immunity responses in allergic asthma. Mol. Immunol. 41:123-131.
49. Kawamoto S, Yalcindag A, Laouini D, Brodeur S, Bryce P, Lu B, Humbles AA, Oettgen H, Gerard C, Geha RS. 2004. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen. J. Clin. Invest. 114:399-407.
50. Niebuhr M, Bäumer W, Kietzmann M, Wichmann K, Heratizadeh A, Werfel T. 2012. Participation of complement 3a receptor (C3aR) in the sensitization phase of Th2 mediated allergic contact dermatitis. Exp. Dermatol. 21:52-56.
51. Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K, Budelsky AL, Wills-Karp M. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11:928-935.
52. Agarwal S, Specht CA, Haibin H, Ostroff GR, Ram S, Rice PA, Levitz SM. 2011. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. mBio 2(5):e00178-11. http://dx.doi.org/10.1128/mBio.00178-11.
53. Rivera A, Ro G, Van Epps HL, Simpson T, Leiner I, Sant'Angelo DB, Pamer EG. 2006. Innate immune activation and CD4_ T cell priming during respiratory fungal infection. Immunity 25:665-675.
54. Rayamajhi M, Redente EF, Condon TV, Gonzalez-Juarrero M, Riches DW, Lenz LL. 2011. Non-surgical intratracheal instillation of mice with analysis of lungs and lung draining lymph nodes by flow cytometry. J. Vis. Exp. 51:e2702. http://dx.doi.org/10.3791/2702.
55. Rozen S, Skaletsky H. 2000. Primer3 on theWWWfor general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
56. Schmittgen TD, Livak KJ. 2008. Clyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3:1101-1108.